Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Perry

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 16, 2011
Glioblastoma: patterns of recurrence and efficacy of salvage treatmentsJiwon Oh, Arjun Sahgal, Paul Sanghera, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 17, 2009
Recurrent PNET with MGMT methylation responds to temozolomideJiwon Oh, Juan M Bilbao, May N Tsao, et al.
Journal of Neuro-Oncology|February 7, 2023
Dose-dependent efficacy of bevacizumab in recurrent glioblastomaJawad M Melhem, Ali Tahir, Eirena Calabrese, et al.
Neuro-Oncology|June 24, 2024
No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patientsMonika E Hegi, Felix B Oppong, James R Perry, et al.
Journal of Neuro-Oncology|April 26, 2006
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiationVictor A Levin, Surasak Phuphanich, W K Alfred Yung, et al.
Annals of Palliative Medicine|September 5, 2017
Hospitalizations in elderly glioblastoma patientsClaire Moroney, James R Perry, Derek S Tsang, et al.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Journal of Virology|July 8, 2011
High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeysAndrew B Wilks, James R Perry, Elizabeth P Ehlinger, et al.
Stroke|October 31, 2009
A citywide prehospital protocol increases access to stroke thrombolysis in TorontoDavid J Gladstone, Lance H Rodan, Demetrios J Sahlas, et al.
Neuro-Oncology|August 21, 2014
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastomaDavid A Reardon, Louis B Nabors, Warren P Mason, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 16, 2011
Glioblastoma: patterns of recurrence and efficacy of salvage treatmentsJiwon Oh, Arjun Sahgal, Paul Sanghera, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 17, 2009
Recurrent PNET with MGMT methylation responds to temozolomideJiwon Oh, Juan M Bilbao, May N Tsao, et al.
Journal of Neuro-Oncology|February 7, 2023
Dose-dependent efficacy of bevacizumab in recurrent glioblastomaJawad M Melhem, Ali Tahir, Eirena Calabrese, et al.
Neuro-Oncology|June 24, 2024
No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patientsMonika E Hegi, Felix B Oppong, James R Perry, et al.
Journal of Neuro-Oncology|April 26, 2006
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiationVictor A Levin, Surasak Phuphanich, W K Alfred Yung, et al.
Annals of Palliative Medicine|September 5, 2017
Hospitalizations in elderly glioblastoma patientsClaire Moroney, James R Perry, Derek S Tsang, et al.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Journal of Virology|July 8, 2011
High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeysAndrew B Wilks, James R Perry, Elizabeth P Ehlinger, et al.
Stroke|October 31, 2009
A citywide prehospital protocol increases access to stroke thrombolysis in TorontoDavid J Gladstone, Lance H Rodan, Demetrios J Sahlas, et al.
Neuro-Oncology|August 21, 2014
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastomaDavid A Reardon, Louis B Nabors, Warren P Mason, et al.
Pageof 5